On repeated neuroimaging, at the end of the follow-up period, the tumor remained stable in 8 patients in each group, progressed in 2 patients with NF-1 and 3 without NF-1, and regressed in 2 patients, both without NF-1, respectively. This evidence concerns the gene NF1 and neoplasm.